Back to results
CompletedPhase 3

A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus

NCT06258148

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Peking University People's Hospital

Beijing, Beijing Municipality, China

View on ClinicalTrials.gov
A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus — TrialFind